This is a really bad article. There is no explanation of the competitive advantages DOW has on it's competitors, of the declining free cash flow to a level lower than the required future dividends, of important balance sheet metrices like current ratio or debt/equity ratios, and of the fact that no matter what the current book value is the current credit environment won't allow any company like this to sell off its assets at their current book value to justify what seems like a "cheap valuation" based on price to book value measures.
Four Reasons to Own Dow Chemical [View article]